Zacks Investment Research·Sep 10, 2026
Why Is AtaiBeckley Inc (ATAI) Up 0.8% Since Last Earnings Report?AtaiBeckley Inc (ATAI) reported earnings 30 days ago. What's next for the stock?
Atai Beckley Inc. presents a high-risk, pre-revenue biotechnology profile, where a recent 137% year-over-year revenue surge to $1.7 million in Q2 2026 is dwarfed by a $28.1 million R&D expense, indicating a heavy, ongoing investment in clinical programs with n...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 11, 2026 | -$0.09+15.6% vs -$0.11 | $900,000+109.1% vs $430,400 |
Q2 2026 May 12, 2026 | -$0.08+27.3% vs -$0.11 | $954,000+339.4% vs $217,111 |
Q2 2026 Mar 6, 2026 | -$0.05+58.3% vs -$0.12 | $1M+255.3% vs $300,000 |
Q4 2025 Nov 12, 2025 | -$0.28-133.3% vs -$0.12 | $749,000+226.8% vs $229,170 |
AtaiBeckley Inc (ATAI) reported earnings 30 days ago. What's next for the stock?
Lilly is expanding its neuroscience pipeline through strong growth and M&A, aiming to build a new long-term driver beyond cardiometabolic therapies.
On CNBC's “Mad Money Lightning Round,” Jim Cramer said he is not sure that there's a lot of upside in AtaiBeckley Inc. (NASDAQ:ATAI).
Are DSGR, HLX, ATAI, CRNX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 17, 2026
Benchmark ATAI against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Atai Beckley Inc. (ATAI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $7.35 | $2.72B | -2.53 | 1227.6% | -16142.02% | -389.92% | — | |
| $13.75 | $1.86B | -4.46 | — | — | -398.21% | — | |
| $42.79 | $3.23B | -20.77 | — | — | -102.48% | — | |
| $6.09 | $303.86M | -13.66 | — | — | -81% | — | |
| $1.77 | $2M | -0.24 | — | -8269.53% | -81.74% | — | |
| $1.57 | $934.32K | -0.04 | — | — | -168.05% | — |
Atai Beckley Inc. (ATAI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Atai Beckley Inc. (ATAI) SEC filings — annual & quarterly reports (10-K, 10-Q)
Dec 5, 2025·SEC
Nov 12, 2025·SEC
Nov 5, 2025·SEC
Get notified when ATAI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Atai Beckley Inc. (ATAI) stock FAQ — growth, dividends, profitability & financials explained
Atai Beckley Inc. (ATAI) reported $4.5M in revenue for fiscal year 2025.
Atai Beckley Inc. (ATAI) grew revenue by 1227.6% over the past year. This is strong growth.
Atai Beckley Inc. (ATAI) reported a net loss of $668.2M for fiscal year 2025.
Atai Beckley Inc. (ATAI) has a return on equity (ROE) of -389.9%. Negative ROE indicates the company is unprofitable.
Atai Beckley Inc. (ATAI) had negative free cash flow of $133.2M in fiscal year 2025, likely due to heavy capital investments.
